Skip to main content
. 2024 Feb 20;30(9):1984–1991. doi: 10.1158/1078-0432.CCR-23-1977

Figure 4.

Figure 4. Time-dependent Kaplan–Meier analysis based on DR comparing extended letrozole verus placebo in subsets of patients with (A) node-negative (N0) or (B) node-positive (N+) disease in the overall BCI NSABP B-42 translational cohort and according to BCI (H/I) status.

Time-dependent Kaplan–Meier analysis based on DR comparing extended letrozole verus placebo in subsets of patients with (A) node-negative (N0) or (B) node-positive (N+) disease in the overall BCI NSABP B-42 translational cohort and according to BCI (H/I) status.